The disease is usually preceded by a premalignant condition (MBL) which shares most molecular drivers with overt CLL. In many cases, these molecular motorists stay regular after a while. Having said that, clonal evolution is likewise feasible and will likely be connected to exponential tumor advancement, progressive condition and, in some cases, co